Agenda for Day 2 – Thursday December 10, 2026Thursday, 10 December 2026 - US/Eastern

As regulatory expectations continue to rise, pharmacies must move beyond minimum compliance requirements and establish quality systems capable of supporting long-term growth.

Discussion Topics

• Inspection readiness strategies

• CAPA effectiveness

• Documentation practices

• Quality culture development

• Long-term compliance sustainability

Compliance investments can strengthen long-term viability—but only when aligned with operational realities and business objectives.

Discussion Topics

• Financial realities of cGMP, QA and infrastructure investment

• Long-term defensibility

• Scaling quality systems

• Avoiding overbuilding or underbuilding

• Balancing compliance and profitability

Veterinary compounding remains a growing area of opportunity but presents unique regulatory and operational considerations.

Discussion Topics

• Regulatory expectations

• Quality considerations

• Veterinary prescribing practices

• Species-specific challenges

• Market opportunities

Session pending – please reach out to Samantha.elizondo@informa.com to propose additional topics not currently covered on the agenda.

Join peers for facilitated, discussions focused on the strategic, operational, and compliance challenges shaping the future of compounding. Attendees will participate in small-group conversations designed to encourage candid dialogue, practical problem-solving, and peer-to-peer knowledge sharing.

Roundtable Topics

• Emerging Business Models: Telehealth, Med Spas, Veterinary, and Other Growth Opportunities

• Navigating Inspections, Audits, and State Board Expectations

• Quality Systems That Scale: Balancing Compliance, Efficiency, and Growth

• Peptides, GLP-1s, and Other High-Interest Compounded Therapies

• Supply Chain, Sourcing, and Distribution Challenges Across Compounding

• Preparing for What’s Next: Industry Trends, Market Pressures, and Strategic Priorities